UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1, 2007
THORATEC CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
California
(State or other jurisdiction
of incorporation)
|
|
1-8145
(Commission file number)
|
|
94-2340464
(I.R.S. Employer
Identification Number) |
| |
|
|
6035 Stoneridge Drive
Pleasanton, California
(Address of principal executive offices)
|
|
94588
(Zip Code) |
Registrant’s telephone number, including area code: (925) 847-8600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 8.01. Other Events.
On March 1, 2007, Thoratec Corporation (“Thoratec”) issued a press release announcing that,
due to its ongoing review of the company’s equity-based compensation practices, including
the underlying documentation and procedures, and related accounting, for such practices, the
filing of its Annual Report on Form 10-K for the year ended December 30, 2006 would be delayed.
A copy of the press release relating to these announcements is attached hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits
| |
|
|
| Exhibit |
|
Description |
|
|
|
99.1
|
|
Press Release of Thoratec Corporation, dated March 1, 2007. |